Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Carmen Ballesteros-Merino
Bristol-Myers Squibb
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
30
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
FcyRIIB Is a Novel Immune Checkpoint in the Tumor Microenvironment Limiting Activity of Treg-Targeting Antibodies
Number of pages: 30
Posted: 20 Jan 2023
David Knorr
,
Rom S. Leidner
,
Shawn Jensen
,
Ryan Meng
,
Andrew Jones
, Carmen Ballesteros-Merino,
R. Bryan Bell
,
Maria Baez
,
David Sprott
,
Carlo B. Bifulco
,
Brian Penning
,
Rony Dahan
,
Bernard Fox
and
Jeffrey Ravetch
Memorial Sloan Kettering Cancer Center - Department of Medicine, Providence Cancer Center - Earle A. Chiles Research Institute, Providence Cancer Center - Earle A. Chiles Research Institute, Providence Cancer Center - Earle A. Chiles Research Institute, Rockefeller University - Laboratory of Molecular Genetics and Immunology, Bristol-Myers Squibb, Providence Cancer Center - Earle A. Chiles Research Institute, Rockefeller University - Laboratory of Molecular Genetics and Immunology, Providence Cancer Center - Earle A. Chiles Research Institute, Providence Cancer Center - Earle A. Chiles Research Institute, Providence Cancer Center - Earle A. Chiles Research Institute, Weizmann Institute of Science - Department of Immunology, Providence Cancer Center - Earle A. Chiles Research Institute and Rockefeller University - Laboratory of Molecular Genetics and Immunology
Downloads
30
(1,345,526)
View PDF
Download
Abstract:
Fc-engineered antibodies, antibody therapy, cancer immunology, immunotherapy, T regulatory cell
Feedback
